Diebold Nixdorf, Incorporated

Diebold Nixdorf, Incorporated

DBDยทNYSE

$81.35

-1.8%
TechnologySoftware - Application

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers cash recyclers and dispensers, intelligent deposit terminals, teller automation tools, and kiosk technologies, as well as physical security solutions; and front-end applications for consumer connection points and back-end platforms that manage channel transactions, operations and integration, and facilitate omnichannel transactions, endpoint monitoring, remote asset management, customer marketing, merchandise management, and analytics. It also provides banking product-related services comprising proactive monitoring and rapid resolution of incidents through remote service capabilities or an on-site visit; first- and second-line maintenance, preventive maintenance, and on-demand services; managed and outsourcing services, such as business processes, solution management, upgrades, and transaction processing; and cash management services. In addition, the company offers DN Vynamic software suite to simplify and enhance the consumer experience; mobile point of sale and self-checkout terminals; printers, scales, and mobile scanners; and banknote and coin processing systems. Additionally, it provides retail customer's product-related services, such as on-demand and professional services; maintenance and availability services; implementation services; managed mobility services; monitoring and advanced analytics; and store life-cycle management services. The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016. Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in Hudson, Ohio.

At a Glance

Live Snapshot
Market Cap$2.82B
EPS2.5700
P/E Ratio31.65
Earnings Date08/05/2026
dbd

Diebold Nixdorf, Incorporated Street Expectations Map

DBD ยท NYSE

Wall Street analysts project that DBD stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 100.00, with estimates ranging from a low of 100.00 to a high of 100.00.

Lowest Target
100.00
22.93%
Consensus Target
100.00
22.93%
Highest Target
100.00
22.93%

The consensus 1-year price target stands at 100.00, with estimates ranging from a low of 100.00 to a high of 100.00.

Analyst Consensus Analysis

Upside Potential

+22.9%

Strong upside potential. Consensus indicates attractive return opportunity with favorable risk-reward profile.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of Revenue

DBD ยท NYSE
Latest Revenue
3.81B
FY 2025
Avg Estimate
3.90B
FY 2026
Estimate Range
3.88B - 3.91B
Analyst Spread

Forward Growth Analysis

Projected Growth+2.4%

Flat growth suggests market maturity or near-term challenges offsetting expansion efforts.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of Net Income

DBD ยท NYSE
Latest Net Income
94.60M
FY 2025
Avg Estimate
188.54M
FY 2026
Estimate Range
187.67M - 189.41M
Analyst Spread

Forward Growth Analysis

Projected Growth+99.3%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of EPS

DBD ยท NYSE
Latest EPS
2.57
FY 2025
Avg Estimate
$5.02
FY 2026
Estimate Range
$4.99 - $5.04
Analyst Spread

Forward Growth Analysis

Projected Growth+95.2%

Strong growth expectations signal robust business momentum and market opportunity expansion.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

Key Insight

Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of EBIT

DBD ยท NYSE
Latest EBIT
334.60M
FY 2025
Avg Estimate
47.30M
FY 2026
Estimate Range
47.11M - 47.45M
Analyst Spread

Forward Growth Analysis

Projected Growth-85.9%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of EBITDA

DBD ยท NYSE
Latest EBITDA
462.10M
FY 2025
Avg Estimate
195.14M
FY 2026
Estimate Range
194.38M - 195.76M
Analyst Spread

Forward Growth Analysis

Projected Growth-57.8%

Significant contraction projectedโ€”major business challenges or industry disruption likely.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookNeutral

Mixed signalsโ€”some positive indicators offset by concerns about growth or uncertainty.

Key Insight

Limited coverage with volatile estimates: Few analysts covering despite significant projected changes may indicate information gaps or emerging risks.

dbd

Diebold Nixdorf, Incorporated Forward Estimates of SG&A Expense

DBD ยท NYSE
Latest SG&A Expense
585.00M
FY 2025
Avg Estimate
626.99M
FY 2026
Estimate Range
624.56M - 628.99M
Analyst Spread

Forward Growth Analysis

Projected Growth+7.2%

Moderate growth expected, typical for mature businesses with stable market positions.

Analyst Coverage2 Analysts

Limited coverage may indicate reduced institutional interest or information availability.

Estimate Spread1%

Narrow estimate range signals strong analyst consensus and predictable business outlook.

OutlookPositive

Generally favorable outlook with reasonable growth prospects and analyst support.

dbd

Diebold Nixdorf, Incorporated Insider Positioning

DBD ยท NYSE

During the last 12 months, insiders have purchased $249K and sold $95.96M worth of DBD shares, resulting in $95.72M of net selling activity.

3 Months

Bought

3.3K

249.14K

Sold

512.2K

42.51M

Net Activity

-42.3M

-$42.27M

3-6 Months

Bought

0

0.00

Sold

500.0K

34.00M

Net Activity

-34.0M

-$34.00M

6-9 Months

Bought

0

0.00

Sold

310.7K

19.45M

Net Activity

-19.4M

-$19.45M

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
MJ

Myers Jonathan

Officer: Evp, Chief Revenue Officer

1.4K sharesโ€ข1 transactions

$100K

2
MO

Marquez Octavio

Director, Officer: President And Ceo

1.3K sharesโ€ข2 transactions

$99K

3
TTS

Timko Thomas S

Officer: Evp, Cfo

672 sharesโ€ข1 transactions

$50K

Top Sellers

1
MCML

Millstreet Capital Management Llc

10 Percent Owner

1.3M sharesโ€ข8 transactions

$95.96M

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $95.72M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$42.27M

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Buying

3 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.